Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290M Buy
6,798,961
+177,422
+3% +$7.93M 0.02% 598
2026
Q1
$319M Buy
6,621,539
+510,665
+8% +$23.8M 0.03% 522
2025
Q4
$296M Buy
6,110,874
+313,327
+5% +$15.5M 0.03% 513
2025
Q3
$274M Sell
5,797,547
-3,390,657
-37% -$164M 0.04% 530
2025
Q2
$444M Sell
9,188,204
-2,671,341
-23% -$136M 0.08% 328
2025
Q1
$658M Sell
11,859,545
-199,738
-2% -$10.8M 0.12% 183
2024
Q4
$582M Buy
12,059,283
+408,752
+4% +$20.8M 0.11% 222
2024
Q3
$671M Buy
11,650,531
+1,138,896
+11% +$61.5M 0.13% 170
2024
Q2
$510M Buy
10,511,635
+3,577,158
+52% +$173M 0.11% 215
2024
Q1
$337M Buy
6,934,477
+15,376
+0.2% +$751K 0.07% 372
2023
Q4
$344M Buy
6,919,101
+88,058
+1% +$4.31M 0.08% 320
2023
Q3
$366M Sell
6,831,043
-24,014
-0.4% -$1.28M 0.1% 264
2023
Q2
$369M Buy
6,855,057
+306,722
+5% +$16.5M 0.1% 265
2023
Q1
$356M Buy
6,548,335
+410,699
+7% +$20M 0.1% 263
2022
Q4
$297M Buy
6,137,636
+556,328
+10% +$24.4M 0.09% 326
2022
Q3
$212M Buy
5,581,308
+188,217
+3% +$8.39M 0.07% 395
2022
Q2
$270M Buy
5,393,091
+315,243
+6% +$16.7M 0.08% 325
2022
Q1
$261M Buy
5,077,848
+112,404
+2% +$5.8M 0.07% 401
2021
Q4
$249M Sell
4,965,444
-359,580
-7% -$17.8M 0.06% 431
2021
Q3
$257M Sell
5,325,024
-104,073
-2% -$5.29M 0.07% 398
2021
Q2
$286M Sell
5,429,097
-106,456
-2% -$5.56M 0.07% 354
2021
Q1
$274M Buy
5,535,553
+4,865
+0.1% +$234K 0.07% 344
2020
Q4
$269M Sell
5,530,688
-1,123,140
-17% -$55.4M 0.08% 323
2020
Q3
$334M Sell
6,653,828
-187,910
-3% -$9.67M 0.11% 207
2020
Q2
$349M Sell
6,841,738
-517,534
-7% -$25.2M 0.12% 184
2020
Q1
$322M Sell
7,359,272
-241,387
-3% -$11.5M 0.14% 175
2019
Q4
$382M Sell
7,600,659
-167,313
-2% -$7.84M 0.12% 205
2019
Q3
$360M Buy
7,767,972
+390,619
+5% +$16.8M 0.09% 237
2019
Q2
$319M Sell
7,377,353
-2,589
-0% -$110K 0.08% 291
2019
Q1
$327M Buy
7,379,942
+23,806
+0.3% +$1.02M 0.11% 213
2018
Q4
$319M Buy
7,356,136
+187,494
+3% +$8.27M 0.12% 187
2018
Q3
$320M Buy
7,168,642
+538,610
+8% +$23M 0.1% 214
2018
Q2
$265M Sell
6,630,032
-253,786
-4% -$9.99M 0.09% 254
2018
Q1
$276M Sell
6,883,818
-98,775
-1% -$4.11M 0.1% 227
2017
Q4
$300M Sell
6,982,593
-416,794
-6% -$19.2M 0.11% 215
2017
Q3
$368M Sell
7,399,387
-762,359
-9% -$36.9M 0.14% 184
2017
Q2
$391M Sell
8,161,746
-142,602
-2% -$6.81M 0.12% 185
2017
Q1
$376M Sell
8,304,348
-542,474
-6% -$23M 0.12% 181
2016
Q4
$358M Sell
8,846,822
-627,285
-7% -$24.7M 0.12% 186
2016
Q3
$362M Sell
9,474,107
-499,485
-5% -$20M 0.12% 186
2016
Q2
$417M Buy
9,973,592
+2,843,613
+40% +$117M 0.15% 150
2016
Q1
$286M Sell
7,129,979
-959,687
-12% -$38.6M 0.12% 200
2015
Q4
$345M Sell
8,089,666
-175,126
-2% -$8.06M 0.14% 168
2015
Q3
$392M Sell
8,264,792
-242,152
-3% -$12.3M 0.17% 133
2015
Q2
$421M Sell
8,506,944
-238,049
-3% -$12.1M 0.17% 141
2015
Q1
$432M Sell
8,744,993
-2,239,615
-20% -$107M 0.17% 134
2014
Q4
$501M Sell
10,984,608
-1,582,132
-13% -$76.8M 0.19% 117
2014
Q3
$709M Buy
12,566,740
+2,658
+0% +$143K 0.28% 64
2014
Q2
$668M Buy
12,564,082
+1,050,614
+9% +$55.8M 0.26% 69
2014
Q1
$602M Buy
11,513,468
+1,480,774
+15% +$75M 0.24% 79
2013
Q4
$538M Buy
10,032,694
+424,215
+4% +$21.9M 0.21% 92
2013
Q3
$486M Sell
9,608,479
-147,182
-2% -$7.49M 0.21% 98
2013
Q2
$503M Buy
+9,755,661
New +$520M 0.23% 90

Other funds holding SNY

Invesco's SNY Position: Q2 2026 in Review

Invesco increased its Sanofi (SNY) stake by 2.7% in Q2 2026, buying an estimated $7.93M and bringing the position to 6,798,961 shares worth $290M. The position accounts for 0.02% of the portfolio, ranked #598.

Invesco first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. The position peaked at $709M in Q3 2014. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Invesco held 6,798,961 shares of Sanofi worth $290M as of Q2 2026.
  • Invesco bought 177,422 Sanofi shares in Q2 2026, an estimated $7.93M.
  • Sanofi made up 0.02% of Invesco's portfolio in Q2 2026, its #598 holding.
  • Invesco first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
  • Invesco's Sanofi position peaked at $709M in Q3 2014.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.